Interesting Engineering on MSN2d
Fukushima disaster: 14 years into Japan’s battle to remove 880 tons of nuclear debris
Fourteen years after the devastating earthquake and tsunami led to the Fukushima Daiichi nuclear accident, the site has made ...
Fierce Biotech2d
Daiichi taps Nosis to deliver RNA therapies beyond the liver
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...
The Diplomat1d
At Fukushima Daiichi, Japan’s Unprecedented Nuclear Cleanup Continues
On March 11, 2025, we remember the profound loss and resilience of the people of Japan following the Great East Japan ...
Devdiscourse2d
Fukushima's Ongoing Battle: A Century-Long Clean-up of Nuclear Debris
Fourteen years after the Fukushima Daiichi meltdown, radiation levels have decreased, but decommissioning efforts remain ...
Japan's top court upholds ex-TEPCO leaders' acquittal on negligence over Fukushima nuclear crisis
Japan’s top court has found two former company executives not guilty of negligence over the 2011 Fukushima Daiichi nuclear power plant disaster and the subsequent deaths of dozens of elderly residents ...
Morningstar1d
Daiichi Sankyo Co Ltd 4568
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Clinical Trials Arena on MSN9d
Daiichi Sankyo and AstraZeneca’s Enhertu shows OS improvements in Phase III trial
Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has shown clinically meaningful 'improvement' in the ...